Public Access Defibrillation (PAD) Community Trial
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00004560 |
Recruitment Status :
Completed
First Posted : February 10, 2000
Last Update Posted : April 14, 2016
|
Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by:
National Heart, Lung, and Blood Institute (NHLBI)
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Brief Summary:
To measure survival to hospital discharge of patients with out-of-hospital cardiac arrest in community units (e.g., apartment or office buildings, gated communities, sports venues, senior centers, shopping malls) served by trained non-medical responders using automated external defibrillators (AEDs), an approach called Public Access Defibrillation, compared to units receiving the traditional optimum community standard of care (i.e., rescuers trained to recognize a cardiac emergency, call 911, and initiate CPR).
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Arrhythmia Heart Arrest Heart Diseases Myocardial Infarction Ventricular Fibrillation Death, Sudden, Cardiac | Device: defibrillator | Phase 3 |

Study Type : | Interventional (Clinical Trial) |
Allocation: | Randomized |
Primary Purpose: | Treatment |
Study Start Date : | September 1999 |
Study Completion Date : | February 2004 |
Resource links provided by the National Library of Medicine

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 75 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Criteria
No eligibility criteria
No Contacts or Locations Provided
Study Data/Documents:
Individual Participant Data Set

Publications:

Identifier: PAD
NHLBI provides controlled access to IPD through BioLINCC. Access requires registration, evidence of local IRB approval or certification of exemption from IRB review, and completion of a data use agreement.
NHLBI provides controlled access to IPD through BioLINCC. Access requires registration, evidence of local IRB approval or certification of exemption from IRB review, and completion of a data use agreement.
Publications:
ClinicalTrials.gov Identifier: | NCT00004560 |
Other Study ID Numbers: |
128 |
First Posted: | February 10, 2000 Key Record Dates |
Last Update Posted: | April 14, 2016 |
Last Verified: | November 2005 |
Additional relevant MeSH terms:
Myocardial Infarction Heart Diseases Ventricular Fibrillation Heart Arrest Death, Sudden, Cardiac Infarction Death, Sudden Ischemia |
Pathologic Processes Necrosis Myocardial Ischemia Cardiovascular Diseases Vascular Diseases Arrhythmias, Cardiac Death |